Where Tech Meets Bio
Latest News
Oracle has launched a new electronic health record (EHR) platform that diverges entirely from the architecture of Cerner, which it acquired in 2022 for $28 …
Read More
CRISPR Therapy Saves Infant With Rare Genetic Disorder
Doctors at Children’s Hospital of Philadelphia have reported a breakthrough use of CRISPR gene editing to treat an infant with severe carbamoyl phosphate synthetase 1 …
Read More
Researchers Use Terahertz Imaging for First-Ever 3D View of Cochlea Without Surgery
In a study published March 27 in Optica, researchers from Waseda, Kobe, and Osaka Universities reported the successful use of terahertz (THz) imaging to non-invasively …
Read More
Latest News
Medable Updates Digital Platform With Oncology-Focused Tools Ahead of ASCO 2025
Absci Doses First Participants in Phase 1 Trial of AI-Designed Antibody for IBD
Eligo Bioscience Gets $5M Grant to Advance Gene-Editing Skin Therapy Using Bacteria
Kvantify Taps Gefion AI Supercomputer to Scale Quantum Chemistry Simulations for Drug Discovery
Dutch Startup CryoCloud Lands €2M to Automate Cryo-EM for Drug Discovery
Valinor Discovery Launches to Simulate Drug Efficacy in Virtual Patients
Latest Insights
by BiopharmaTrend
FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth
FTI Consulting’s Healthcare & Life Sciences Outlook Survey surveyed 250 U.S.-based decision-makers from corporate communications, investor relations, public affairs, business development, and marketing roles in …
Read More
by Andreas Dreps, Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 …
Read More
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Lantern Pharma
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Partner Events

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››
Case Studies
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Interviews
Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
This South Korean Company is at the Forefront of AI-driven Drug Discovery
Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics
[Interview] How D-Wave Brings Quantum Computing Into Biology
Most Read
The Increasing Role of CROs in the Pharmaceutical Industry
10 Companies Applying AI for Biologics Discovery
9 Notable AI Companies in Clinical Research to Watch in 2023
13 Publicly Traded Biotechs Utilizing AI-based Research Platforms (+ 2 Upcoming Public Debuts)